1. Borsook H (1964) DNA, RNA and protein synthesis after acute severe blood loss. A picture of erythropoiesis at the combined morphological and molecular levels. Ann NY Acad Sci 119: 523
2. Chabner BA, Myers CE (1985) Clinical pharmacology of cancer chemotherapy. In: De Vita VI, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 2nd edn., vol 1. Lippincott, p 309
3. Charry KK, Higby DJ, Henderson CS, Swinerton KD (1977) A phase I study of high dose cis-diamminnedichloroplatinum II (NSC 119875) with forced diuresis. J Clin Haematol Oncol 7: 633
4. Comis RL (1980) Cisplatin nephrotoxicity: the effect of dose, schedule and hydration scheme. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: current status and new developments. Academic, New York p 485
5. Connors BT (1982) Platinum compounds. In: Holland JF, Frei E (eds) Cancer medicine, 2nd edn. Lea and Febiger, p 843